155 related articles for article (PubMed ID: 12905011)
1. The late consequences of anthracycline treatment on left ventricular function after treatment for childhood cancer.
Elbl L; Hrstkova H; Chaloupka V
Eur J Pediatr; 2003 Oct; 162(10):690-6. PubMed ID: 12905011
[TBL] [Abstract][Full Text] [Related]
2. The evaluation of left ventricular function in childhood cancer survivors by pharmacological stress echocardiography.
Elbl L; Hrstkova H; Chaloupka V; Novotny J; Michalek J
Neoplasma; 2003; 50(3):191-7. PubMed ID: 12937852
[TBL] [Abstract][Full Text] [Related]
3. Late anthracycline cardiotoxicity protection by dexrazoxane (ICRF-187) in pediatric patients: echocardiographic follow-up.
Elbl L; Hrstkova H; Tomaskova I; Michalek J
Support Care Cancer; 2006 Feb; 14(2):128-36. PubMed ID: 16034614
[TBL] [Abstract][Full Text] [Related]
4. Subclinical anthracycline-induced cardiotoxicity in long-term follow-up of asymptomatic childhood cancer survivors: Assessment by speckle tracking echocardiography.
Çetin S; Babaoğlu K; Başar EZ; Deveci M; Çorapçıoğlu F
Echocardiography; 2018 Feb; 35(2):234-240. PubMed ID: 29106752
[TBL] [Abstract][Full Text] [Related]
5. Left ventricular systolic and diastolic function after anthracycline chemotherapy in childhood.
Iarussi D; Galderisi M; Ratti G; Tedesco MA; Indolfi P; Casale F; Di Tullio MT; de Divitiis O; Iacono A
Clin Cardiol; 2001 Oct; 24(10):663-9. PubMed ID: 11594412
[TBL] [Abstract][Full Text] [Related]
6. [Changes in left ventricular function during chemotherapy with doxorubicin].
Elbl L; Chaloupka V; Vásová I; Kiss I; Jancík J; Vorlícek J; Navrátil M
Vnitr Lek; 1999 Jul; 45(7):395-402. PubMed ID: 11045157
[TBL] [Abstract][Full Text] [Related]
7. Left ventricular diastolic function after anthracycline chemotherapy in childhood: relation with systolic function, symptoms, and pathophysiology.
Bu'Lock FA; Mott MG; Oakhill A; Martin RP
Br Heart J; 1995 Apr; 73(4):340-50. PubMed ID: 7756067
[TBL] [Abstract][Full Text] [Related]
8. [Dynamic stress echocardiography in asymptomatic patients treated for malignant diseases in childhood].
Elbl L; Hrstková H; Chaloupka V; Novotný J
Vnitr Lek; 2003 Apr; 49(4):273-9. PubMed ID: 12793049
[TBL] [Abstract][Full Text] [Related]
9. Long-term serial echocardiographic examination of late anthracycline cardiotoxicity and its prevention by dexrazoxane in paediatric patients.
Elbl L; Hrstkova H; Tomaskova I; Blazek B; Michalek J
Eur J Pediatr; 2005 Nov; 164(11):678-84. PubMed ID: 16044276
[TBL] [Abstract][Full Text] [Related]
10. Left ventricular strain and strain rates are decreased in children with normal fractional shortening after exposure to anthracycline chemotherapy.
Moon TJ; Miyamoto SD; Younoszai AK; Landeck BF
Cardiol Young; 2014 Oct; 24(5):854-65. PubMed ID: 24044518
[TBL] [Abstract][Full Text] [Related]
11. Late echocardiography assessment of systolic and diastolic function of the left ventricle in pediatric cancer survivors after anthracycline therapy.
Santin JC; Deheinzelin D; Junior SP; Lopes LF; de Camargo B
J Pediatr Hematol Oncol; 2007 Nov; 29(11):761-5. PubMed ID: 17984694
[TBL] [Abstract][Full Text] [Related]
12. Relationship between cumulative anthracycline dose and late cardiotoxicity in childhood acute lymphoblastic leukemia.
Nysom K; Holm K; Lipsitz SR; Mone SM; Colan SD; Orav EJ; Sallan SE; Olsen JH; Hertz H; Jacobsen JR; Lipshultz SE
J Clin Oncol; 1998 Feb; 16(2):545-50. PubMed ID: 9469339
[TBL] [Abstract][Full Text] [Related]
13. [Monitoring cardiotoxicity of anthracyclines in children and possibilities of its prevention].
Sromová T; Strnadová V; Hrstková H
Vnitr Lek; 2002 Jul; 48(7):649-56. PubMed ID: 12197409
[TBL] [Abstract][Full Text] [Related]
14. Cardiac functions by myocardial performance index and QT dispersion in survivors of childhood lymphoblastic leukaemia.
Gulen H; Kazanci E; Mese T; Uzunkaya D; Erbay A; Tavli V; Vergin C
Minerva Pediatr; 2007 Apr; 59(2):107-13. PubMed ID: 17404560
[TBL] [Abstract][Full Text] [Related]
15. Chronic progressive cardiac dysfunction years after doxorubicin therapy for childhood acute lymphoblastic leukemia.
Lipshultz SE; Lipsitz SR; Sallan SE; Dalton VM; Mone SM; Gelber RD; Colan SD
J Clin Oncol; 2005 Apr; 23(12):2629-36. PubMed ID: 15837978
[TBL] [Abstract][Full Text] [Related]
16. Anthracycline dose in childhood acute lymphoblastic leukemia: issues of early survival versus late cardiotoxicity.
Sorensen K; Levitt G; Bull C; Chessells J; Sullivan I
J Clin Oncol; 1997 Jan; 15(1):61-8. PubMed ID: 8996125
[TBL] [Abstract][Full Text] [Related]
17. Echocardiographic evaluation of cardiac function in paediatric oncology patients treated with or without anthracycline.
Sung RY; Huang GY; Shing MK; Oppenheimer SJ; Li CK; Li CK; Lau J; Yuen MP
Int J Cardiol; 1997 Aug; 60(3):239-48. PubMed ID: 9261634
[TBL] [Abstract][Full Text] [Related]
18. Dynamic stress echocardiography in asymptomatic patients who received chemotherapy in childhood because of a malignant disease.
Elbl L; Hrstkova H; Chaloupka V; Michalek J
Kardiol Pol; 2003 Mar; 58(3):190-6. PubMed ID: 14513093
[TBL] [Abstract][Full Text] [Related]
19. [Comparison of plasmatic levels of B-natriuretic peptide with echocardiographic indicators of left ventricle function after doxorubicin therapy].
Elbl L; Vásová I; Navrátil M; Vorlícek J; Malásková L; Spinar J
Vnitr Lek; 2006 Jun; 52(6):563-70. PubMed ID: 16871759
[TBL] [Abstract][Full Text] [Related]
20. Lack of clinically significant cardiac dysfunction during intermediate dobutamine doses in long-term childhood cancer survivors exposed to anthracyclines.
Lanzarini L; Bossi G; Laudisa ML; Klersy C; Aricò M
Am Heart J; 2000 Aug; 140(2):315-23. PubMed ID: 10925349
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]